ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2332

Rheumatoid Arthritis Effect´s on Bone Mass and Muscle

María Lorena Brance1, Bernardo A Pons-Estel2, Javier Quagliatto3, Marisa Jorfen4, Noel Cortese4, Guillermo Berbotto5, Juan Carlos Raggio6, Juan Soldano3, Mariano Palatnik1, Ignacio Chavero1, Carolina Dieguez1, Silvana Di Gregorio7 and Lucas Ricardo Brun8, 1Centro de Reumatología, Rosario, Argentina, 2Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Rosario, Argentina, 3Hospital Provincial, Rosario, Argentina, 4Municipalidad de Rosario, Rosario, Argentina, 5Hospital Escuela Eva Perón, Granadero Baigorria, Argentina, Granadero Baigorria, Argentina, 6Hospital Eva Perón, Granadero Baigorria, Argentina, 7Centre Medic Cetir, Barcelona, Spain, 8School of Medicine. Rosario National University, Bone Biology Laboratory, Rosario, Argentina

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Muscle strength, osteopenia, Osteoporosis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is a progressive auto-immune disease characterized by chronic inflammation which leads to joint deformity and disability. However, the bone and muscle are also affected. The aim of this study was to evaluate the total bone mineral density (tBMD) and total lean mass in rheumatoid arthritis patients.

Methods: A total of 50 adult´s women with RA and a control group (CG, n=34) matched by sex, age and body mass index (BMI) were included. All patients had more than 18 years and were from Rosario city (32º52´18´´S), Argentina. Exclusion criteria: pregnancy, intestinal malabsorption, chronic liver or kidney disease, cancer and drug which could affected the bone mass except glucocorticoids. The whole body composition was performed by Dual X-Ray Absorptiometry (DXA) (Hologic discovery Wi). The muscle strength was evaluated by handgrip strength (Baseline Hydraulic Hand Dynamometer, USA) and the physical performance by sit to stand test and timed up and go test. Date are expressed as mean±SD. Differences between groups were analyzed using the Student t test or Mann-Whitney test as appropriate. Correlations were performed with Pearson or Spearman’s correlation test. Contingency tables were evaluated with c2 test. The difference was considered significant if p<0.05.

Results: No differences in age (CG: 55.1±12.7 y, RA: 53.5±11.7 y), BMI (CG: 26.0±5.1, RA: 27.8±4.6) and percentage of pre and postmenopausal women were included. According to BMI no differences in total mass by DXA were observed (CG: 66.9±13.1 kg, RA: 68.0±13.1 kg). The total bone mineral content (tBMC) and tBMD were found decreased in RA patients (tBMC= CG: 2111±319 g, RA: 1874±343 g, p=0.0036; tBMD= CG: 1.072±0.094 g/cm2, RA: 1.016±0.109 g/cm2, p=0.0255). Furthermore, a tendency to low lean mass in RA patients were observed (CG: 57.3±5.2, RA: 55.7±5.3, p=0.06). The muscular involvement was confirmed in muscle strength and physical performance tests. The RA group had significantly lower handgrip strength (CG: 21.4±4.9 kg, RA: 12.3±6.7, p<0.0001), lower performance in the sit to stand test (CG: 14.7±4.5 s, RA: 17.9±5.7 s, p=0.0126) and timed up and go test (CG: 8.8±1.9 s, RA: 11.6±3.7, p=0.0003). A significant correlation between tBMD and total lean mass were found (r: 0.3, p=0.0128). In addition, significant correlation between regional BMD (left arm, right arm, left leg and right leg) and the lean mass of each region were observed. Therefore the loss of lean mass could explain the loss of bone mass. On the other hand, higher percentage of fat was found in RA patients (CG: 39.4±5.7, RA: 41.9±5.7, p=0.06).

Conclusion: the disease activity could affect not only the joint and bone mass, but also the muscle which contributes to bone loss and lead to osteopenia and osteoporosis in RA patients.


Disclosure: M. L. Brance, None; B. A. Pons-Estel, None; J. Quagliatto, None; M. Jorfen, None; N. Cortese, None; G. Berbotto, None; J. C. Raggio, None; J. Soldano, None; M. Palatnik, None; I. Chavero, None; C. Dieguez, None; S. Di Gregorio, None; L. R. Brun, None.

To cite this abstract in AMA style:

Brance ML, Pons-Estel BA, Quagliatto J, Jorfen M, Cortese N, Berbotto G, Raggio JC, Soldano J, Palatnik M, Chavero I, Dieguez C, Di Gregorio S, Brun LR. Rheumatoid Arthritis Effect´s on Bone Mass and Muscle [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/rheumatoid-arthritis-effects-on-bone-mass-and-muscle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-effects-on-bone-mass-and-muscle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology